Metastatic Breast Cancer Clinical Trials in Birmingham, Alabama
7 recruitingBirmingham, Alabama
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center201 enrolled12 locationsNCT06099769
Recruiting
Phase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Metastatic Breast CancerInvasive Mammary Carcinoma
Sonya Reid64 enrolled3 locationsNCT05693766
Recruiting
Phase 2
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
Metastatic Breast Cancer
University of Alabama at Birmingham40 enrolled1 locationNCT06105684
Recruiting
Phase 2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Metastatic Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerRecurrent Breast Cancer
Puma Biotechnology, Inc.150 enrolled53 locationsNCT06369285
Recruiting
Phase 2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Breast CancerMetastatic Breast CancerHER2-low Breast Cancer+1 more
Ana C Garrido-Castro, MD357 enrolled11 locationsNCT06533826
Recruiting
Not Applicable
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Breast CancerMetastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center120 enrolled2 locationsNCT06855654
Recruiting
Phase 1
PRE-I-SPY Phase I/Ib Oncology Platform Program
Metastatic Breast CancerHER2-negative Breast CancerMetastatic Cancer+5 more
QuantumLeap Healthcare Collaborative124 enrolled7 locationsNCT05868226